klindavag 100 mg/1 vagitorija vagitorija
farmalogist allbix d.o.o. bijeljina - klindamicin - vagitorija - 100 mg/1 vagitorija - 1 vaginaleta sadrži: 100 mg klindamicina (u obliku klindamicin fosfata)
stulipor 100 mg/1 vagitorija vagitorija
oktal pharma d.o.o. sarajevo - klindamicin - vagitorija - 100 mg/1 vagitorija - jedna vagitorija sadrži: 100 mg klindamicina (u obliku 119 mg klindamicin fosfata)
medishield antiadhezivni gel
medic d.o.o., zagreb - antiadhezivni gel kao privremena mehanička barijera koja odvaja suprotne površine tkiva u svrhu ublažavanja boli, radikulopatije
avishield ib gi-13
genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - Živi virus zaraznog bronhitisa kokoši, varijantni soj v-173/11 - liofilizat za okulonazalnu suspenziju/primjenu u vodi za piće - kokoši
pegasys
pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - Иммуностимуляторы, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 i 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. s poštovanjem za rješavanje započeti liječenje u pedijatrijska bolesnika vidi 4. 2, 4. 4 i 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip određene aktivnosti, vidi 4. 2 i 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. pri rješavanju početak liječenja u dječjoj dobi, važno je uzeti u obzir inhibicija rasta, izazvana kombinovanu terapiju. Обратимость inhibicije rasta povjerenja. odluka mora biti donesena na individualnoj osnovi (vidi odjeljak 4.
avishield nd
genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - živi, lentogeni virus newcastleske bolesti, soj la sota - liofilizat za okulonazalnu suspenziju/primjenu u vodi za piće, za kokoši i purane - kokoši, purana